ClinicalMetric / Countries / Czech Republic / pancreatitis chronic
← 🇨🇿 Czech Republic Trials
🇨🇿 Czech Republic Country × Condition

pancreatitis chronic Clinical Trials in Czech Republic

Active clinical trials for pancreatitis chronic with research sites in Czech Republic. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 2 // Recruiting: 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇨🇿 Czech Republic

Active Trials in Czech Republic (2)

NCT06549725
Recruiting

Clinical Performance of Medical Device Software "Lipidica 1.0" for Processing Data Generated by Lipidomic Analysis in Pancreatic Cancer Screening

Enrollment
419 pts
Country
🇨🇿 Czech Republic
Lipidica, a.s.
View Trial →
NCT06330441
Recruiting

Pancreatic Cancer Screening in a Population at High Risk

Enrollment
700 pts
Country
🇨🇿 Czech Republic
Masaryk Memorial Cancer Institute
View Trial →

Frequently Asked Questions

How many pancreatitis chronic clinical trials are active in Czech Republic?
There are currently 2 active clinical trials for pancreatitis chronic with sites in Czech Republic, of which 2 are actively recruiting patients.
How can I join a pancreatitis chronic clinical trial in Czech Republic?
To join a pancreatitis chronic clinical trial in Czech Republic, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Czech Republic directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are pancreatitis chronic trials in Czech Republic?
Active pancreatitis chronic trials in Czech Republic span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Czech Republic Trials → Global pancreatitis chronic Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology